Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Literature DB >> 21925739

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Jagadeesh Sridhara Rao¹, Matthew Kellom², Edmund Arthur Reese², Stanley Isaac Rapoport², Hyung-Wook Kim².

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of The National Institutes of Health has found that the first author, Dr. Jagadeesh S. Rao engaged in research misconduct by falsifying data in “Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients”. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. J. Affect Disord. 136(1–2):63–71. 2012. Data in Figures 2A, 2B, 3A, 3B and 4A were falsified. Published by Elsevier B.V.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21925739 PMCID： PMC3254216 DOI： 10.1016/j.jad.2011.08.017

Source DB: PubMed Journal: J Affect Disord ISSN： 0165-0327 Impact factor: 4.839

71 in total

1. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors: K J Livak; T D Schmittgen
Journal: Methods Date: 2001-12 Impact factor: 3.608

2. Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes.

Authors: Zhiyi Zuo; Hongyu Fang
Journal: J Exp Biol Date: 2005-06 Impact factor: 3.312

3. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.

Authors: T L Lauriat; S Dracheva; B Chin; J Schmeidler; L A McInnes; V Haroutunian
Journal: Neuroscience Date: 2005-11-16 Impact factor: 3.590

4. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats.

Authors: Mireille Basselin; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal: Neuropsychopharmacology Date: 2005-11-09 Impact factor: 7.853

Review 5. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?

Authors: André Nieoullon; Benoit Canolle; Frédérique Masmejean; Benjamin Guillet; Pascale Pisano; Sylviane Lortet
Journal: J Neurochem Date: 2006-06-27 Impact factor: 5.372

6. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

Authors: T A Greenwood; N J Schork; E Eskin; J R Kelsoe
Journal: Mol Psychiatry Date: 2006-02 Impact factor: 15.992

Review 7. Schizophrenia and bipolar disorder: differences and overlaps.

Authors: Wolfgang Maier; Astrid Zobel; Michael Wagner
Journal: Curr Opin Psychiatry Date: 2006-03 Impact factor: 4.741

8. Atypical antipsychotics in bipolar depression: potential mechanisms of action.

Authors: Lakshmi N Yatham; Jeffrey M Goldstein; Eduard Vieta; Charles L Bowden; Heinz Grunze; Robert M Post; Trisha Suppes; Joseph R Calabrese
Journal: J Clin Psychiatry Date: 2005 Impact factor: 4.384

9. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.

Authors: S Horschitz; R Hummerich; T Lau; M Rietschel; P Schloss
Journal: Mol Psychiatry Date: 2005-12 Impact factor: 15.992

10. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors: Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal: Am J Psychiatry Date: 2003-12 Impact factor: 18.112

50 in total

Review 1. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors: Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal: Neurosci Biobehav Rev Date: 2015-08-19 Impact factor: 8.989

2. White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress.

Authors: Sara Poletti; Irene Bollettini; Cristina Lorenzi; Alice Vitali; Silvia Brioschi; Alessandro Serretti; Cristina Colombo; Francesco Benedetti
Journal: Mol Neurobiol Date: 2018-05-22 Impact factor: 5.590

Review 10. Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.

Authors: Grace Y Sun; Dennis Y Chuang; Yijia Zong; Jinghua Jiang; James C M Lee; Zezong Gu; Agnes Simonyi
Journal: Mol Neurobiol Date: 2014-02-27 Impact factor: 5.590

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

1. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

2. Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes.

3. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.

4. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats.

Review 5. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?

6. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

Review 7. Schizophrenia and bipolar disorder: differences and overlaps.

8. Atypical antipsychotics in bipolar depression: potential mechanisms of action.

9. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.

10. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Review 1. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

2. White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress.

3. Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.

Review 4. Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Review 5. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Review 6. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

7. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.

8. Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.

9. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Review 10. Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.